BiondVax Announces Launch of Proposed Underwritten…
JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a!-->!-->!-->…
JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a!-->!-->!-->…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.